» Articles » PMID: 30964778

EARLY VITAMIN A SUPPLEMENTATION IMPROVES THE OUTCOME OF RETINOPATHY OF PREMATURITY IN EXTREMELY PRETERM INFANTS

Overview
Journal Retina
Date 2019 Apr 10
PMID 30964778
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: This study assessed the efficacy and safety of early vitamin A (VA) supplementation to improve outcomes of retinopathy of prematurity in extremely preterm infants.

Methods: A total of 262 eligible extremely preterm infants underwent randomization; of these, 132 were assigned to the VA group and 130 to the control group. The infants were administered a solution of VA (1,500 IU/day), added to their enteral feeds as soon as minimal feeding was introduced and continued for 28 days or until discharge.

Results: With no adverse effects occurring, serum VA of the VA-supplemented infants on Days 14, 28, and postmenstrual 36 weeks was higher than that of the placebo group (P < 0.001). No signs of VA toxicity or increased intracranial pressure were reported. The VA group had lower unadjusted rates of Type 1 retinopathy of prematurity (1.6 vs. 6.9%, P = 0.030) and bronchopulmonary dysplasia (18.9 vs. 33.8%, P = 0.008) than the control group. Regression analysis revealed an association between serum VA levels and risk of Type 1 retinopathy of prematurity (beta = -2.37).

Conclusion: Vitamin A supplementation reduced VA deficiency in extremely preterm infants; it was associated with a decreased incidence of Type 1 retinopathy of prematurity and may also have a positive impact on reducing bronchopulmonary dysplasia.

Citing Articles

Efficacy and Safety of Prophylactic Agents in Prevention of Retinopathy of Prematurity: A Systematic Review and Meta-analysis of Randomised Controlled rials.

Batais W, Taher N, Alhindi A, Ghaddaf A, Alamoudi A, Al-Ghamdi S BMJ Open Ophthalmol. 2024; 9(1).

PMID: 39721967 PMC: 11683937. DOI: 10.1136/bmjophth-2024-001910.


A promising case of preclinical-clinical translation: β-adrenoceptor blockade from the oxygen-induced retinopathy model to retinopathy of prematurity.

Cammalleri M, Filippi L, Dal Monte M, Bagnoli P Front Physiol. 2024; 15:1408605.

PMID: 38938747 PMC: 11208707. DOI: 10.3389/fphys.2024.1408605.


Effects of primary or secondary prevention with vitamin A supplementation on clinically important outcomes: a systematic review of randomised clinical trials with meta-analysis and trial sequential analysis.

Bjelakovic G, Nikolova D, Bjelakovic M, Pavlov C, Sethi N, Korang S BMJ Open. 2024; 14(5):e078053.

PMID: 38816049 PMC: 11141198. DOI: 10.1136/bmjopen-2023-078053.


The role of nutritional interventions in the prevention and treatment of chronic lung disease of prematurity.

Saenz de Pipaon M, Nelin L, Gehred A, Rossholt M, Moltu S, Van den Akker C Pediatr Res. 2024; .

PMID: 38565917 DOI: 10.1038/s41390-024-03133-3.


Retinopathy of Prematurity-Targeting Hypoxic and Redox Signaling Pathways.

Zhang L, Buonfiglio F, Fiess A, Pfeiffer N, Gericke A Antioxidants (Basel). 2024; 13(2).

PMID: 38397746 PMC: 10885953. DOI: 10.3390/antiox13020148.


References
1.
Landman J, Sive A, HEESE H, van der Elst C, Sacks R . Comparison of enteral and intramuscular vitamin A supplementation in preterm infants. Early Hum Dev. 1992; 30(2):163-70. DOI: 10.1016/0378-3782(92)90143-5. View

2.
Cavallaro G, Filippi L, Bagnoli P, la Marca G, Cristofori G, Raffaeli G . The pathophysiology of retinopathy of prematurity: an update of previous and recent knowledge. Acta Ophthalmol. 2013; 92(1):2-20. DOI: 10.1111/aos.12049. View

3.
Wang L, Shi P, Xu Z, Li J, Xie Y, Mitton K . Up-regulation of VEGF by retinoic acid during hyperoxia prevents retinal neovascularization and retinopathy. Invest Ophthalmol Vis Sci. 2014; 55(7):4276-87. DOI: 10.1167/iovs.14-14170. View

4.
Longardt A, Schmiedchen B, Raila J, Schweigert F, Obladen M, Buhrer C . Characterization of the vitamin A transport in preterm infants after repeated high-dose vitamin A injections. Eur J Clin Nutr. 2014; 68(12):1300-4. DOI: 10.1038/ejcn.2014.202. View

5.
ZACHMAN R, Samuels D, Brand J, Winston J, Pi J . Use of the intramuscular relative-dose-response test to predict bronchopulmonary dysplasia in premature infants. Am J Clin Nutr. 1996; 63(1):123-9. DOI: 10.1093/ajcn/63.1.123. View